NFKB1 and metabolic dysfunction-associated steatotic liver disease: Progressive NAFLD can be induced in mice through genetic manipulation of independent regulatory molecules affecting NF-κB-mediated transcription, demonstrating involvement of this signaling pathway in disease development.